The fourth fund of ULB’s venture unit now stands at $41.2m having extended its investment purview to include spinouts in Quebec.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Chernin Group has returned for the meditation platform's $93m series C round, while Bennett Coleman & Co took part as a new investor.

VR mental health software developer Oxford VR secured the return of both OUI and OSI to increase its funding to more than $17m.

Biopsy verification technology developer Strand Diagnostics had raised $7.5m of a commitment from Nantworks originally slated to reach $30m.

D1 Capital Partners has led a series E round for Outset Medical, pushing the OSU dialysis device spinout’s overall funding to more than $430m.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The genomic drug developer, spun out of Harvard University, has completed its initial public offering, boosting its size from $180m to $207m.

The genomic drug developer, which counts GV as an investor, has completed its initial public offering, boosting its size from $180m to $207m.

D1 Capital Partners has led a series E round for Outset Medical, pushing the Baxter-backed dialysis device developer’s overall funding to more than $430m.